Thu September 28, 2023

Upcoming Medicare Drug-Price Negotiations: An Investment Perspective

Many countries, among them Canada, Japan, the United Kingdom, Germany, and France, negotiate directly with pharmaceutical companies to set prices of vital prescription medications on behalf of their respective residents....

Tue August 8, 2023

Pharmaceutical stocks look attractive

MARKETS HAVE ENTERED A WINDOW WHERE A POTENTIAL LOW COULD TAKE PLACE THIS WEEK (LIKELY WEDNESDAY-FRIDAY OF THIS WEEK).  US DOLLAR AND US TREASURY YIELDS LOOK TO BE ON THE...

Thu July 20, 2023

Defensives finally strengthening as key Cycle date nears

MARKETS HAVE ENTERED A WINDOW FOR POTENTIAL SHORT-TERM TREND CHANGE, BUT DO NOT EXPECT MUCH SELLING UNTIL AUGUST.  NEAR-TERM, AN SPX-4500-4600 RANGE MIGHT HOLD INTO LAST COUPLE DAYS OF JULY...

Tue May 2, 2023

LIVE Technical Stock Analysis May 2023

Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute of analysis) and consider several...

Wed April 5, 2023

Defensive trading dominates as Pharma, & Utilities break out

Similar to Tuesday’s mild “down day,” Wednesday’s pullback failed to show sufficient deterioration to expect much follow-through just yet. The key driver of this rally, Technology, has not given much...

Tue January 31, 2023

Healthcare should soon hit support and reverse in February

January’s strong gains suggest that the bullish Pre-election year seasonality trends likely outweigh the bearish forecasts about how dismal earnings should be, and the NASDAQ managed to log its best...

Mon September 19, 2022

Tough to trust SPX bounce with $TNX making new 2022 highs

Ahead of this week’s Fed meeting, Monday’s minor relief rally took prices right back to areas of September’s breakdown, which at $SPY-389 is thought to be quite important resistance.  Given...